MG Med Inc <180400.KQ> :Says it will raise 4.5 bln won in private offering of shares.
MG Med Inc <180400.KQ> :Says it will raise 3.5 billion won in private offering of shares.
Roka Bioscience Inc : Files for public offering of up to 62.8 million shares of Co's common stock by selling stockholders - SEC filing .Co will not receive any cash proceeds from the sale of any of shares of common stock by the selling stockholders..
Newron Pharmaceuticals Spa : Raises 26.1 million Swiss francs ($26.58 million) in a private placement of new shares .Has placed 1,320,530 new shares with institutional investors at a subscription price of 19.75 Swiss francs per share.
Newron Pharmaceuticals SpA : Launches private placement of new shares . Up to 10 pct of the company's share capital .Intends to use the net proceeds of the issuance for general corporate purposes.
Genfit SA : Genfit raises 33.9 million euros in private placement . Has placed 1,695,000 new ordinary shares at a price of 20.00 euros per share . Offering represents 6.4 pct of pre-transaction share capital . This Private Placement is the first step of a c. EUR 75-80 million fundraising .If all of the Company's programs are implemented at the pace currently expected by the Company, the proceeds of the global fundraising, together with its cash on hand, should allow the Company to finance its development until late 2018-early 2019.
Probiodrug AG :Announces pricing of a 14.9 million euros ($16.68 million) accelerated bookbuild offering of new shares.
Genfit SA : Genfit launches a share capital increase through private placement . Company targets raising around 30 million euros ($33.6 million) through private placement .Private placement is first step of around 75-80 million euros fundraising.
Probiodrug AG : Intends to issue up to 744,248 new shares . To increase share capital of company by 744,248 euros, from 7,442,487 euros($8.33 million)to 8,186,735 euros, against cash contribution . Probiodrug launches capital increase by means of an accelerated bookbuild offering . New shares represent up to approximately 10% of company's issued share capital .Offering will take place by means of an accelerated bookbuilding.